ENSC 10-Q: SEC filing
Ensysce Biosciences
Filed with the SEC on · accession 0001493152-26-051422
ENSC filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +7.5% by the first close after the filing.
Summary of the filing
Ensysce Biosciences filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosing recent financing activities including a Series C preferred stock PIPE financing and warrant settlements.
Key details
How ENSC stock reacted
Close before
$0.36
Nov 11, 2026
First close after
+7.53%
$0.39
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for ENSC, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ENSC?
Click hereFrequently asked questions
What did ENSC file with the SEC on Nov 12, 2026?
ENSC filed a 10-Q (SEC filing). Ensysce Biosciences filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosing recent financing activities including a Series C preferred stock PIPE financing and warrant settlements.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did ENSC stock react to this filing?
ENSC closed at $0.36 before the filing and $0.39 on Nov 12, 2026 (+7.53%).
Other ENSC SEC filings
Get alerts when ENSC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days